Vyome Holdings (HIND) Change in Cash (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Change in Cash of $3.8 million for Q1 2026, up 8859.71% year-over-year from $42562.2 in Q1 2025, and up 626.23% quarter-over-quarter from -$724679.0 in Q4 2025.
Vyome Holdings (HIND) Change in Cash (2015 - 2026) Analysis & Trends
Vyome Holdings' Change in Cash history runs 12 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Change in Cash rose 8859.71% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $8.7 million (up 311.81% YoY), while the FY2025 annual figure was $4.9 million, up 5624.37% from the prior year.
- Change in Cash for Q1 2026 stood at $3.8 million, up from -$724679.0 in the prior quarter.
- The five-year high for Change in Cash was $5.1 million in Q1 2023, with the low at -$7.4 million in Q1 2022.
- The 5-year median for Change in Cash is -$724679.0 (2025), against an average of -$557462.6.
- The sharpest annual moves came in 2025 and 2026: Change in Cash tumbled 1466.52% in 2025, then jumped 8859.71% in 2026.
- Vyome Holdings' Change in Cash stood at -$2.3 million in 2022, then soared by 231.44% to $3.0 million in 2023, then plunged by 98.24% to $53031.0 in 2024, then sank by 1466.52% to -$724679.0 in 2025, then soared by 626.23% to $3.8 million in 2026.
- Business Quant data shows HIND's Change in Cash at $3.8 million in Q1 2026, -$724679.0 in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -908,273.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -908,273.00 |
| Mar 31, 2026 | 3.81 Mn |
| Dec 31, 2025 | -724,679.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 3.47 Mn |
| Mar 31, 2025 | -43,534.00 |
| Dec 31, 2024 | 53,031.00 |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | -2.08 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | -3.12 Mn |
| Jun 30, 2023 | -4.42 Mn |
| Mar 31, 2023 | 5.13 Mn |
| Dec 31, 2022 | -2.29 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | -3.92 Mn |
| Mar 31, 2022 | -7.36 Mn |
| Dec 31, 2021 | -6.48 Mn |
| Sep 30, 2021 | -10.92 Mn |